Intelligence · Clinical Development
Pipeline search results
Programs matching “tasimelteon” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 18 pipeline programs matching "tasimelteon" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
TASIMELTEON, HETLIOZ 20 mg hard capsules
Lacuna Pharma Pty Ltd
Non-24 Hour Sleep-Wake Disorder
1 trial -
Tasimelteon
Vanda Pharmaceuticals Netherlands B.V.
Jet Lag Type Insomnia
1 trial -
Tasimelteon
Vanda Pharmaceuticals Netherlands B.V.
Sleep Wake Disorders
2 trials -
Tasimelteon Oral Suspension
Vanda Pharmaceuticals Netherlands B.V.
Insomnia Disorder
1 trial -
VP-VEC-162-3601
Vanda Pharmaceuticals Netherlands B.V.
Autism Spectrum Disorder
1 trial -
tasimelteon
Vanda Pharmaceuticals Netherlands B.V.
Smith-Magenis Syndrome
1 trial -
tasimelteon
Vanda Pharmaceuticals Netherlands B.V.
Major Depressive Disorder
1 trial -
tasimelteon
Vanda Pharmaceuticals Netherlands B.V.
Non 24 Hour Sleep Wake Disorder
4 trials -
Tasimelteon
Vanda Pharmaceuticals Netherlands B.V.
Jet Lag Disorder
1 trial -
Tasimelteon
Vanda Pharmaceuticals Netherlands B.V.
REM Behavior Disorder
1 trial -
Tasimelteon
Vanda Pharmaceuticals Netherlands B.V.
Renal Impairment
1 trial -
Tasimelteon
Vanda Pharmaceuticals Netherlands B.V.
Healthy Volunteers
4 trials -
Tasimelteon Oral Capsule
Vanda Pharmaceuticals Netherlands B.V.
Healthy
1 trial -
tasimelteon
Vanda Pharmaceuticals Netherlands B.V.
Pharmacodyamics and Pharmacokinetics of Tasimelteon Alone and in Combination With Ethanol
1 trial -
tasimelteon
Vanda Pharmaceuticals Netherlands B.V.
Circadian Rhythm Sleep Disorders
1 trial -
tasimelteon
Vanda Pharmaceuticals Netherlands B.V.
Hepatic Impairment
1 trial -
tasimelteon
Vanda Pharmaceuticals Netherlands B.V.
Healthy
1 trial -
tasimelteon 20 mg capsule
Vanda Pharmaceuticals Netherlands B.V.
Non-24-Hour-Sleep-Wake Disorder
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.